Synergistic interaction between amyloid and tau predicts the progression to dementia
Abstract
Recent literature proposes that amyloid β (Aβ) and phosphorylated tau (p‐tau) synergism accelerates biomarker abnormalities in controls. Yet, it remains to be answered whether this synergism is the driving force behind Alzheimer disease (AD) dementia.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 23, 2016
- Source ID
- 10.1016/j.jalz.2016.11.005
Entities
People
- Andrea L Benedet
- Aurelie Labbe
- Jean‐paul Soucy
- Min Su Kang
- Monica Shin
- Pedro Rosa‐neto
- Sara Mohades
- Seqian Wang
- Serge Gauthier
- Sulantha Mathotaarachchi
- Tharick A Pascoal
- Tom Beaudry
Organizations
- Alzheimer's Association
- Canadian Institutes of Health Research
- McGill University
- McGill University Health Centre
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- United States Department of Defense